Diamond Biofund Inc.

Equities

6901

TW0006901002

Investment Management & Fund Operators

End-of-day quote Taiwan S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
39.7 ^TWD	+2.19%		+2.06%	-18.65%

05-21	Diamond Biofund Inc. Approves Election of Directors of Board	CI
05-10	Diamond Biofund Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Ativa Medical Corporation announced that it expects to receive $15 million in funding.

August 13, 2015

Ativa Medical Corporation announced that it will receive $15,000,000 in funding on August 14, 2015. The company will issue convertible series B-2 preferred stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.

Latest news about Diamond Biofund Inc.

Diamond Biofund Inc. Approves Election of Directors of Board	05-21	CI
Diamond Biofund Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Diamond Biofund Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Diamond Biofund Inc. Announces Chief Financial Officer Changes	12-22	CI
Diamond Biofund Inc.(TWSE:6901) added to Taiwan TAIEX Index	12-15	CI
Diamond Biofund Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07	CI
Diamond Biofund Inc. has completed an IPO in the amount of TWD 4 billion.	23-09-15	CI
Diamond Biofund Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Diamond Biofund Inc. Appoints Patricia Chou as CFO	23-07-20	CI
Diamond Biofund Inc. Announces a Cash Dividend, Payable on September 8, 2023	23-07-20	CI
Diamond Biofund Inc. has filed an IPO in the amount of TWD 4 billion.	23-07-20	CI
Diamond Biofund Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Diamond Biofund Inc.(TPEX:6901) added to S&P Global BMI Index	22-12-19	CI
Ativa Medical Corporation announced that it has received $15 million in funding from Ping An Ventures, Zhejiang Dian Diagnostics Co., Investment Arm, Diamond Biofund Inc., Hermed Capital co.,Ltd, Laboratory Corp. of America Holdings, GIMDx, and other investors.	15-08-27	CI
Ativa Medical Corporation announced that it expects to receive $15 million in funding.	15-08-13	CI

Chart Diamond Biofund Inc.

Duration

Period

More charts

Company Profile

Diamond Biofund Inc is a Taiwan-based company primarily engaged in the venture capital and general investment industries. The Company focuses on investments in the biotechnology and medical fields. Main investment areas include new drug research and development, high-end medical devices, innovative medical service technologies or models, medical access, and agricultural biotechnology. The Company's investments are primarily in the domestic sector.

Sector

Investment Management & Fund Operators

Calendar

2024-08-06 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
DIAMOND BIOFUND INC.	-18.65%	1.04B
BLACKROCK, INC.	-4.90%	115B
UBS GROUP AG	+9.16%	101B
BROOKFIELD CORPORATION	+11.67%	67.41B
APOLLO GLOBAL MANAGEMENT, INC.	+24.65%	66.1B
BANK OF NEW YORK MELLON CORPORATION (THE)	+14.52%	44.58B
AMERIPRISE FINANCIAL, INC.	+14.85%	43.37B
3I GROUP PLC	+18.26%	35.13B
T. ROWE PRICE GROUP INC.	+9.42%	26.31B
STATE STREET CORPORATION	-2.41%	22.77B

Other Investment Management & Fund Operators